BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27262205)

  • 1. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
    Abrantes CG; Duarte D; Reis CP
    J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of pharmaceutical excipients.
    Pifferi G; Restani P
    Farmaco; 2003 Aug; 58(8):541-50. PubMed ID: 12875883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipients.
    Abdellah A; Noordin MI; Wan Ismail WA
    Saudi Pharm J; 2015 Jan; 23(1):9-13. PubMed ID: 25685037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach to the safety assessment of pharmaceutical excipients. The Safety Committee of the International Pharmaceutical Excipients Council.
    Steinberg M; Borzelleca JF; Enters EK; Kinoshita FK; Loper A; Mitchell DB; Tamulinas CB; Weiner ML
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):149-54. PubMed ID: 8933628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics.
    Rayaprolu BM; Strawser JJ; Anyarambhatla G
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review on pharmaceutical excipients.
    Pockle RD; Masareddy RS; Patil AS; Patil PD
    Ther Deliv; 2023 Jul; 14(7):443-458. PubMed ID: 37464784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vendor qualification for pharmaceutical excipients--GMP requirements and approach.
    Patel KT; Chotal NP
    Pharmazie; 2010 Nov; 65(11):783-90. PubMed ID: 21155382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excipient Stability in Oral Solid Dosage Forms: A Review.
    Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
    AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision Support for Excipient Risk Assessment in Pharmaceutical Manufacturing.
    Bejarano A; Hewa Nadungodage C; Wang F; Catlin AC; Hoag SW
    AAPS PharmSciTech; 2019 Jun; 20(6):223. PubMed ID: 31214878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best practices for selection of excipients for paediatrics - Workshop reflection.
    Salunke S; Clapham D; Agrawal A; Hughes K; Nunn T
    Eur J Pharm Biopharm; 2021 Mar; 160():77-81. PubMed ID: 33400989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review.
    Caballero ML; Quirce S
    J Investig Allergol Clin Immunol; 2020; 30(6):400-408. PubMed ID: 32376520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of common pharmaceutical excipients on the gut microbiota.
    Subramaniam S; Kamath S; Ariaee A; Prestidge C; Joyce P
    Expert Opin Drug Deliv; 2023; 20(10):1297-1314. PubMed ID: 37307224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.
    Chadha R; Bhandari S
    J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility.
    Wu Y; Levons J; Narang AS; Raghavan K; Rao VM
    AAPS PharmSciTech; 2011 Dec; 12(4):1248-63. PubMed ID: 21948318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version.
    Salunke S; Brandys B; Giacoia G; Tuleu C
    Int J Pharm; 2013 Nov; 457(1):310-22. PubMed ID: 24070789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicines containing pharmaceutical excipients with known effects: a French review.
    Fusier I; Tollier C; Husson MC
    Pharm World Sci; 2003 Aug; 25(4):152-5. PubMed ID: 12964493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging the Gap: A Comparative Investigation of Pharmaceutical Excipient Regulations.
    Mali A; Kuvar V; Bharadwaj S
    Ther Innov Regul Sci; 2024 Mar; 58(2):258-272. PubMed ID: 38055157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of excipients on transporter mediated absorption.
    Goole J; Lindley DJ; Roth W; Carl SM; Amighi K; Kauffmann JM; Knipp GT
    Int J Pharm; 2010 Jun; 393(1-2):17-31. PubMed ID: 20417699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical excipient development: the need for preclinical guidance.
    Baldrick P
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):210-8. PubMed ID: 11067777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.